USA-based Kiora Pharmaceuticals has secured exclusive rights outside of Asia to develop and commercialize KIO-401, an oral ...
Boston, USA-based biotech Celea Therapeutics, which is developing therapies for severe respiratory diseases, has announced ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized an expanded indication for US drugmaker ...
Anglo-Swedish pharma major AstraZeneca reported third-quarter 2026 total revenue of $16.21 billion, up 7% at constant ...
The European Medicines Agency’s (EMA) pharmacovigilance committee (PRAC) said it has started the review of depression and ...
French pharma major Sanofi (Euronext: SAN) reported third-quarter sales of 14,444 million euros ($16,625 million), up 16.2%, ...
The biopharmaceutical industry in America directly employs more than 1 million people and drives $1.74 trillion in economic ...
Flagship Pioneering has formed Etcelera through a merger of the platforms of three of its companies, Cellarity, Etiome and ...
October 2026 brought important advances in rare disease treatment, but its most consequential developments may concern how ...
Gilead Sciences shares closed up 6.4% and rose a further 4.5% in after-market trading to $173.00 yesterday, after it ...
Sweden-based Simris Group, a developer of antibody-drug conjugates (ADCs) built on amanitin payloads, has appointed András ...
Drug developers are gaining more ways to investigate how a medicine might affect people before it enters clinical trials. Human tissues grown in laboratories, devices that reproduce aspects of an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results